[go: up one dir, main page]

ZA986596B - Mammalian cytokine related reagents - Google Patents

Mammalian cytokine related reagents

Info

Publication number
ZA986596B
ZA986596B ZA986596A ZA986596A ZA986596B ZA 986596 B ZA986596 B ZA 986596B ZA 986596 A ZA986596 A ZA 986596A ZA 986596 A ZA986596 A ZA 986596A ZA 986596 B ZA986596 B ZA 986596B
Authority
ZA
South Africa
Prior art keywords
related reagents
mammalian cytokine
cytokine related
mammalian
reagents
Prior art date
Application number
ZA986596A
Other languages
English (en)
Inventor
J Fernando Bazan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA986596(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA986596B publication Critical patent/ZA986596B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA986596A 1997-07-25 1998-07-23 Mammalian cytokine related reagents ZA986596B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25

Publications (1)

Publication Number Publication Date
ZA986596B true ZA986596B (en) 1999-02-08

Family

ID=25413278

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986596A ZA986596B (en) 1997-07-25 1998-07-23 Mammalian cytokine related reagents

Country Status (29)

Country Link
EP (3) EP2233574A1 (xx)
JP (5) JP4316133B2 (xx)
KR (1) KR100666835B1 (xx)
CN (2) CN101851286A (xx)
AR (2) AR017510A1 (xx)
AT (1) ATE443142T1 (xx)
AU (1) AU741046B2 (xx)
BR (1) BR9811039A (xx)
CA (1) CA2296272C (xx)
CO (1) CO4810232A1 (xx)
CZ (1) CZ300958B6 (xx)
DE (1) DE69841161D1 (xx)
DK (2) DK1002084T3 (xx)
ES (2) ES2331762T3 (xx)
HK (1) HK1024932A1 (xx)
HU (1) HU230629B1 (xx)
ID (1) ID28114A (xx)
IL (3) IL134068A0 (xx)
LT (1) LT2100959T (xx)
MY (1) MY157028A (xx)
NO (1) NO329329B1 (xx)
NZ (1) NZ502391A (xx)
PE (1) PE20000183A1 (xx)
PL (1) PL197150B1 (xx)
PT (2) PT1002084E (xx)
SK (1) SK287198B6 (xx)
TW (1) TWI237057B (xx)
WO (1) WO1999005280A1 (xx)
ZA (1) ZA986596B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
WO1999020652A1 (fr) * 1997-10-23 1999-04-29 Nippon Institute For Biological Science Facteur stimulant les colonies de granulocytes de felins
WO1999040195A1 (en) * 1998-02-06 1999-08-12 Schering Corporation Mammalian receptor proteins; related reagents and methods
DE69942607D1 (de) 1998-04-14 2010-09-02 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
JP4505166B2 (ja) * 1999-09-09 2010-07-21 シェーリング コーポレイション 哺乳動物インターロイキン−12p40およびインターロイキンb30、その組成物、抗体、薬学的組成物における使用
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
EP3184637A1 (en) 1999-09-09 2017-06-28 Merck Sharp & Dohme Corp. Mammalian interleukin-12 p40 and interleukin b30 complexes, antibodies, uses in pharmaceutical compositions
MXPA05004512A (es) 2002-10-30 2005-07-26 Genentech Inc Inhibicion de la produccion de il-17.
JP2007515939A (ja) 2003-05-09 2007-06-21 セントカー・インコーポレーテツド IL−23p40特異的免疫グロブリン由来タンパク質、組成物、方法および用途
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
TR201902033T4 (tr) 2005-06-30 2019-03-21 Janssen Biotech Inc Anti-IL-23 antikorları, bileşimleri, yöntemleri ve kullanımları.
PL3219328T3 (pl) 2005-12-29 2020-12-14 Janssen Biotech, Inc Ludzkie przeciwciała skierowane przeciw IL-23, kompozycje, sposób i zastosowania
US7790862B2 (en) 2006-06-13 2010-09-07 Zymogenetics, Inc. IL-17 and IL-23 antagonists and methods of using the same
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Il-23拮抗劑於治療感染之用途
WO2009068627A2 (en) 2007-11-27 2009-06-04 Ablynx N.V. Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
JP2011519911A (ja) 2008-05-05 2011-07-14 ノヴィミュンヌ エスア 抗il17a/il−17f交差反応抗体及びその使用方法
CA2759848C (en) 2009-05-05 2018-12-04 Novimmune S.A. Anti-il-17f antibodies and methods of use thereof
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
MY162791A (en) 2010-11-04 2017-07-14 Boehringer Ingelheim Int Anti-il-23 antibodies
WO2013165791A1 (en) 2012-05-03 2013-11-07 Boehringer Ingelheim International Gmbh Anti-il-23p19 antibodies
SG10201805015TA (en) 2013-03-15 2018-07-30 Amgen Inc Methods for treating crohn's disease using an anti-il23 antibody
AP2015008803A0 (en) 2013-03-15 2015-10-31 Amgen Inc Methods for treating psoriasis using an anti-il-23antibody
EP3172339A1 (en) 2014-07-24 2017-05-31 Boehringer Ingelheim International GmbH Biomarkers useful in the treatment of il-23a related diseases
ES2887549T3 (es) 2014-09-03 2021-12-23 Boehringer Ingelheim Int Compuesto dirigido a IL-23A y TNF-alfa y usos del mismo
JP6909208B2 (ja) 2015-09-17 2021-07-28 アムジェン インコーポレイテッド Il23経路バイオマーカーを使用するil23アンタゴニストに対する臨床応答の予測
US11220541B2 (en) 2015-12-22 2022-01-11 Amgen Inc. CCL20 as a predictor of clinical response to IL23-antagonists
KR20210032441A (ko) 2018-07-13 2021-03-24 아스트라제네카 콜라보레이션 벤처스, 엘엘씨 브라지쿠맙을 이용한 궤양성 대장염의 치료
US11548941B2 (en) 2018-11-20 2023-01-10 Janssen Biotech, Inc. Safe and effective method of treating psoriasis with anti-IL-23 specific antibody
JP2022534020A (ja) 2019-05-23 2022-07-27 ヤンセン バイオテツク,インコーポレーテツド Il-23及びtnfアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
WO2021126435A1 (en) 2019-12-20 2021-06-24 Novarock Biotherapeutics, Ltd. Anti-interleukin-23 p19 antibodies and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
EP0088994B1 (en) 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
DE69942607D1 (de) * 1998-04-14 2010-09-02 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein

Also Published As

Publication number Publication date
NO20000343L (no) 2000-03-24
CA2296272C (en) 2012-03-13
EP2100959A2 (en) 2009-09-16
EP2100959B1 (en) 2016-12-07
HUP0004019A3 (en) 2003-08-28
HU230629B1 (hu) 2017-04-28
IL134068A (en) 2010-11-30
JP2015037405A (ja) 2015-02-26
BR9811039A (pt) 2000-08-08
HUP0004019A2 (en) 2001-03-28
PL338262A1 (en) 2000-10-09
CZ300958B6 (cs) 2009-09-23
NO20000343D0 (no) 2000-01-24
JP2013034480A (ja) 2013-02-21
LT2100959T (lt) 2017-01-10
JP2005323610A (ja) 2005-11-24
PT1002084E (pt) 2009-12-16
KR100666835B1 (ko) 2007-01-11
IL134068A0 (en) 2001-04-30
JP2010011863A (ja) 2010-01-21
NO329329B1 (no) 2010-09-27
EP1002084B1 (en) 2009-09-16
EP2233574A1 (en) 2010-09-29
CN1271387A (zh) 2000-10-25
ATE443142T1 (de) 2009-10-15
EP2100959A3 (en) 2009-10-14
PE20000183A1 (es) 2000-03-11
JP2001511347A (ja) 2001-08-14
HK1024932A1 (en) 2000-10-27
CN101851286A (zh) 2010-10-06
AR017510A1 (es) 2001-09-12
ES2610483T3 (es) 2017-04-27
DE69841161D1 (de) 2009-10-29
DK2100959T3 (en) 2017-01-30
EP1002084A1 (en) 2000-05-24
PT2100959T (pt) 2017-01-09
MY157028A (en) 2016-04-15
CA2296272A1 (en) 1999-02-04
DK1002084T3 (da) 2010-01-04
NZ502391A (en) 2002-12-20
AU8589498A (en) 1999-02-16
WO1999005280A1 (en) 1999-02-04
TWI237057B (en) 2005-08-01
AR086483A2 (es) 2013-12-18
IL205765A (en) 2015-07-30
JP4316133B2 (ja) 2009-08-19
SK287198B6 (sk) 2010-03-08
AU741046B2 (en) 2001-11-22
PL197150B1 (pl) 2008-03-31
IL205765A0 (en) 2011-07-31
ID28114A (id) 2001-05-03
CZ2000263A3 (cs) 2000-06-14
ES2331762T3 (es) 2010-01-14
KR20010022214A (ko) 2001-03-15
CO4810232A1 (es) 1999-06-30
SK912000A3 (en) 2000-09-12

Similar Documents

Publication Publication Date Title
ZA986596B (en) Mammalian cytokine related reagents
HUP0100436A3 (en) Mammalian cytokine-like polypeptide-10
AU7103198A (en) Mammalian cytokines; related reagents and methods
IL148300A0 (en) Mammalian cytokines; related reagents and methods
GB9719044D0 (en) Assay
ZA98412B (en) Fermenter
AU3574997A (en) Mammalian chemokine reagents
GB9815224D0 (en) Assay
IL133582A0 (en) Mammalian neuro-growth factor like protein
AU7276098A (en) Mammalian cytokine-like receptor
GB9701710D0 (en) Mammalian protein
GB9715522D0 (en) Assays
IL143052A0 (en) Mammalian chondromodulin-like protein
GB9721240D0 (en) Assay
GB2329925B (en) Panel support member
ZA989343B (en) Mammalian cytokines; related reagents.
GB9701050D0 (en) Structural member
PL340723A1 (en) Structural member
GB9727277D0 (en) Assay
AU6762398A (en) Mammalian cytokine receptor
GB9719428D0 (en) Assay
IL133715A0 (en) Mammalian secretory peptide-9
ZA985390B (en) Mammalian genes; related reagents
PL322145A1 (en) Shaped structural member
AU4133497A (en) Mammalian cytokine, related reagents